Tisdag 29 September | 17:30:22 Europe / Stockholm
Est. tid*
2027-02-11 08:10 Bokslutskommuniké 2026
2026-08-20 - Kvartalsrapport 2026-Q2
2026-03-24 - X-dag halvårsutdelning NSIS B 2
2026-03-23 - Årsstämma
2026-02-25 - Bokslutskommuniké 2025
2025-08-25 - X-dag halvårsutdelning NSIS B 2.25
2025-08-21 - Kvartalsrapport 2025-Q2
2025-04-04 - X-dag halvårsutdelning NSIS B 2.1
2025-04-03 - Årsstämma
2025-02-26 - Bokslutskommuniké 2024
2024-08-30 - X-dag halvårsutdelning NSIS B 2
2024-08-28 - Kvartalsrapport 2024-Q2
2024-05-01 - X-dag halvårsutdelning NSIS B 2
2024-04-30 - Årsstämma
2024-03-04 - Extra Bolagsstämma 2024
2024-02-08 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-10-13 - X-dag bonusutdelning NSIS B 4.2
2023-08-09 - Kvartalsrapport 2023-Q2
2023-04-26 - Kvartalsrapport 2023-Q1
2023-03-30 - Extra Bolagsstämma 2023
2023-03-03 - X-dag ordinarie utdelning NSIS B 6.00 DKK
2023-03-02 - Årsstämma
2023-01-26 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-04-27 - Kvartalsrapport 2022-Q1
2022-03-17 - X-dag ordinarie utdelning NSIS B 5.50 DKK
2022-03-16 - Årsstämma
2022-02-01 - Bokslutskommuniké 2021
2021-10-27 - Kvartalsrapport 2021-Q3
2021-08-12 - Kvartalsrapport 2021-Q2
2021-04-27 - Kvartalsrapport 2021-Q1
2021-03-12 - X-dag ordinarie utdelning NSIS B 5.25 DKK
2021-03-11 - Årsstämma
2021-02-02 - Bokslutskommuniké 2020
2020-10-21 - Kvartalsrapport 2020-Q3
2020-08-12 - Kvartalsrapport 2020-Q2
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-27 - X-dag ordinarie utdelning NSIS B 5.25 DKK
2020-02-26 - Årsstämma
2020-01-23 - Bokslutskommuniké 2019
2019-10-23 - Kvartalsrapport 2019-Q3
2019-08-08 - Kvartalsrapport 2019-Q2
2019-04-24 - Kvartalsrapport 2019-Q1
2019-02-28 - X-dag ordinarie utdelning NSIS B 5.00 DKK
2019-02-27 - Årsstämma
2019-01-24 - Bokslutskommuniké 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-08-10 - Kvartalsrapport 2018-Q2
2018-04-25 - Kvartalsrapport 2018-Q1
2018-03-14 - X-dag ordinarie utdelning NSIS B 4.50 DKK
2018-03-13 - Årsstämma
2018-02-07 - Bokslutskommuniké 2017
2017-10-25 - Kvartalsrapport 2017-Q3
2017-08-11 - Kvartalsrapport 2017-Q2
2017-04-26 - Kvartalsrapport 2017-Q1
2017-02-23 - X-dag ordinarie utdelning NSIS B 4.00 DKK
2017-02-22 - Årsstämma
2017-01-18 - Bokslutskommuniké 2016
2016-10-26 - Kvartalsrapport 2016-Q3
2016-08-10 - Kvartalsrapport 2016-Q2
2016-04-20 - Kvartalsrapport 2016-Q1
2016-02-25 - X-dag ordinarie utdelning NSIS B 3.50 DKK
2016-02-24 - Årsstämma
2016-01-19 - Bokslutskommuniké 2015
2015-10-22 - Kvartalsrapport 2015-Q3
2015-08-06 - Kvartalsrapport 2015-Q2
2015-04-23 - Kvartalsrapport 2015-Q1
2015-02-26 - X-dag ordinarie utdelning NSIS B 3.00 DKK
2015-02-25 - Årsstämma
2015-01-20 - Bokslutskommuniké 2014
2014-10-23 - Kvartalsrapport 2014-Q3
2014-08-14 - Kvartalsrapport 2014-Q2
2014-04-24 - Kvartalsrapport 2014-Q1
2014-02-27 - X-dag ordinarie utdelning NSIS B 2.50 DKK
2014-02-26 - Årsstämma
2014-01-21 - Bokslutskommuniké 2013
2013-10-25 - Kvartalsrapport 2013-Q3
2013-08-09 - Kvartalsrapport 2013-Q2
2013-04-25 - Kvartalsrapport 2013-Q1
2013-03-01 - X-dag ordinarie utdelning NSIS B 2.20 DKK
2013-02-28 - Årsstämma
2012-10-25 - Kvartalsrapport 2012-Q3
2012-08-16 - Kvartalsrapport 2012-Q2
2012-04-25 - Kvartalsrapport 2012-Q1
2012-03-01 - X-dag ordinarie utdelning NSIS B 1.90 DKK
2012-02-29 - Årsstämma
2012-01-19 - Bokslutskommuniké 2011
2011-11-28 - Split NSIS B 1:5
2011-10-28 - Kvartalsrapport 2011-Q3
2011-08-11 - Kvartalsrapport 2011-Q2
2011-04-29 - Kvartalsrapport 2011-Q1
2011-03-03 - X-dag ordinarie utdelning NSIS B 8.00 DKK
2011-03-02 - Årsstämma
2011-01-21 - Bokslutskommuniké 2010
2010-10-28 - Kvartalsrapport 2010-Q3
2010-08-12 - Kvartalsrapport 2010-Q2
2010-04-29 - Kvartalsrapport 2010-Q1
2010-03-04 - X-dag ordinarie utdelning NSIS B 5.75 DKK
2010-03-03 - Årsstämma
2009-03-05 - X-dag ordinarie utdelning NSIS B 5.25 DKK
2008-03-06 - X-dag ordinarie utdelning NSIS B 5.00 DKK
2007-03-09 - X-dag ordinarie utdelning NSIS B 4.50 DKK
2006-03-02 - X-dag ordinarie utdelning NSIS B 4.00 DKK
2005-03-17 - X-dag ordinarie utdelning NSIS B 3.50 DKK
2004-03-18 - X-dag ordinarie utdelning NSIS B 3.15 DKK
2003-03-20 - X-dag ordinarie utdelning NSIS B 2.25 DKK
2002-03-21 - X-dag ordinarie utdelning NSIS B 2.00 DKK
2001-03-22 - X-dag ordinarie utdelning NSIS B 1.65 DKK
LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriBioteknik
Novonesis är verksamma inom biokemi. Bolaget utvecklar enzymer och mikroorganismer för industriellt bruk. Enzymerna är ett protein som används inom ett flertal olika branscher, huvudsakligen inom jordbruks- och livsmedelsindustrin. Produkterna används inom livsmedel samt kläder, och försäljning innehas på global nivå, med störst närvaro inom Norden och Europa. Bolaget har sitt huvudkontor i Bagsværd.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing

2026-09-28 15:35:07

WEST ALLIS, Wis., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, announced the completion of a major expansion at its West Allis, Wisconsin production facility. The investment increases the company’s North American production capacity for dairy cultures, boosting fermentation capacity by approximately 66% and packaging capacity by 17%, while establishing West Allis as one of the world's largest lactobacillus production facilities. The additional capacity will allow Novonesis to help customers keep pace with booming consumer demand for more nutritious foods without compromising taste, texture or quality, while reinforcing Wisconsin’s role as a leader in dairy manufacturing and innovation. 

"For nearly a century, West Allis has played an important role in helping advance dairy innovation," said Theis Bacher, Senior Vice President, Food & Beverage, Novonesis North America. "Today, it serves as our North American center of excellence for food cultures. This expansion builds on that legacy, strengthening our ability to continue delivering the biosolutions our customers rely on while investing in the people, manufacturing capabilities and technology that will help shape the future of dairy. By enabling dairy manufacturers to produce nutritious, high-quality foods more efficiently and sustainably, we're helping advance healthier living through biology." 

“This investment is also a commitment to the West Allis community, reinforcing our dedication to providing high-quality, high-performing cultures to customers in Wisconsin and around the world,” said Anders Lund, Chief Operating Officer and Executive Vice President, Novonesis. “As ‘America’s Dairyland,’ Wisconsin takes great pride in its dairy heritage, and we are proud to be a leader in culture ingredients that support dairies and food manufacturers from farm to fork.” 

While the current expansion adds new jobs and significant production capacity, the site layout allows for additional growth over time by leveraging existing infrastructure along with automation and robotics. The project also incorporates energy-efficient equipment, water reuse, and waste heat recovery to reduce the environmental footprint of operations. Together, these enhancements expand Novonesis’ ability to produce the biosolutions food manufacturers rely on every day, helping customers improve how food is produced while supporting a more efficient, resilient bioeconomy. 

From the cultures used to make cheese and yogurt to innovations that help manufacturers improve product quality, reduce waste and operate more efficiently, Novonesis’ biosolutions help make nutritious dairy foods more accessible while supporting a more sustainable food system and advancing healthier lives on a healthier planet. 

“Wisconsin’s dairy leadership has always been built on the combination of tradition and innovation,” said John Umhoefer, executive director of the Wisconsin Cheese Makers Association. “Investments in advanced dairy manufacturing capabilities help strengthen the infrastructure our cheesemakers rely on, support skilled jobs and reinforce Wisconsin’s ability to remain at the forefront of dairy production. Novonesis’ continued investment in West Allis is another example of the innovation happening across our state’s dairy industry.” 

The West Allis site opened in 1929 and has long been part of Wisconsin's dairy industry. Today, the facility employs 360 people and supplies cultures to dairy manufacturers across North America. The completion of the expansion marks another milestone in the site's nearly century-long history of supporting dairy innovation and manufacturing.  

Novonesis celebrated the completion of the expansion with a ribbon-cutting ceremony attended by customers, employees, community leaders and industry partners.  Guests toured the expanded production facility and customer experience center, highlighting the technologies and capabilities that will support the next generation of dairy manufacturing. 

About Novonesis 

Novonesis is a global biosolutions company leading the era of biosolutions. By leveraging the power of microbiology with science, Novonesis transforms the way the world produces, consumes, and lives. Across more than 30 industries, Novonesis biosolutions are already creating value for thousands of customers while benefiting the planet. With more than 11,000 employees worldwide, Novonesis partners with businesses and communities to better our world with biology.